MedPath

Effect of Thickened Feeds on Clinical Outcomes in Children With Brief Resolved Unexplained Event

Recruiting
Conditions
Oropharyngeal Dysphagia
Apparent Life Threatening Event
Brief Resolved Unexplained Event
Interventions
Dietary Supplement: Thickened feeds
Dietary Supplement: Non-thickened feeds
Registration Number
NCT04477460
Lead Sponsor
Boston Children's Hospital
Brief Summary

This observational study will examine the effects of thickened feeds on clinical outcomes and healthcare utilization in infants with brief resolved unexplained event (BRUE).

Detailed Description

Brief resolved unexplained events (BRUE) are frightening episodes characterized by the appearance of life-threatening choking, pallor, cyanosis, and limpness in infants. These common events are resource-intensive and current management approaches inadequately address persistent symptoms. Infants with BRUE commonly have oropharyngeal dysphagia with aspiration, which is a modifiable risk factor for persistent symptoms, but there are no studies determining the mechanism behind this swallowing dysfunction and if swallowing interventions reduce morbidity. This is a prospective, longitudinal cohort study of infants who experienced brief resolved unexplained event receiving thickened feedings compared to those not receiving thickened feedings over 1 year.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Less than 1 year of age
  • Admitted to Boston Children's Hospital after experiencing first lifetime brief resolved unexplained event.
Exclusion Criteria
  • Any pre-existing medical diagnoses that exclude brief resolved unexplained event diagnosis including seizure disorders and cyanotic congenital heart disease
  • Already receiving thickened liquids for treatment of another condition

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Infants with BRUE receiving thickened feedsThickened feeds-
Infants with BRUE not receiving thickened feedsNon-thickened feeds-
Primary Outcome Measures
NameTimeMethod
Frequency of persistent symptoms and repeat hospitalizations over 6-month follow-up period6 months

Frequency of persistent symptoms and repeat hospitalizations over the 6 months after enrollment, with a comparison between those receiving and not receiving thickened feeds.

Secondary Outcome Measures
NameTimeMethod
Frequency of persistent symptoms and hospitalization risk over the full 12-month follow-up period12 months

Symptoms and hospitalization risk over the full 12-month follow-up period, optimal period of time needed for thickening, parent-reported anxiety levels, cost of care at Boston Children's Hospital, potential adverse effects of thickening, and urine arsenic levels, all compared between subjects receiving and not receiving thickened feeds.

Trial Locations

Locations (1)

Boston Children's Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath